180 Life Sciences Piaci kupak
Mi az 180 Life Sciences Piaci kupak?
A Piaci kupak az 180 Life Sciences Corp. - $11.75M
Mi a Piaci kupak meghatározása?
A piaci kapitalizáció a tőzsdén jegyzett társaság részvényeinek egy adott időpontban érvényes piaci értéke, amely megegyezik a fennálló részvények számának azon időpontjában érvényes részvényárral .
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Piaci kupak a Health Care szektor a NASDAQ-on cégekben a 180 Life Sciences -hoz képest
Mit csinál 180 Life Sciences?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
piaci kupak -hoz hasonló cégek 180 Life Sciences
- Sandmartin International nak Piaci kupak $11.72M van
- NanoVibronix Inc nak Piaci kupak $11.73M van
- Frankly nak Piaci kupak $11.73M van
- Growners SA nak Piaci kupak $11.73M van
- LFG Investment nak Piaci kupak $11.74M van
- Global Net Lease nak Piaci kupak $11.74M van
- 180 Life Sciences nak Piaci kupak $11.75M van
- Chembio Diagnostics nak Piaci kupak $11.75M van
- Lykis nak Piaci kupak $11.75M van
- Steel City Securities nak Piaci kupak $11.75M van
- Blue Star Foods nak Piaci kupak $11.76M van
- UMT United Mobility Technology AG nak Piaci kupak $11.76M van
- Coffee Co Inc nak Piaci kupak $11.76M van